X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (18) 18
female (15) 15
male (14) 14
adult (13) 13
hematology (13) 13
aged (12) 12
middle aged (12) 12
transplantation (8) 8
adolescent (6) 6
young adult (6) 6
blood donors (5) 5
ferritin (5) 5
anemia (4) 4
anemia, iron-deficiency - blood (4) 4
ferritins - blood (4) 4
graft vs host disease - immunology (4) 4
graft vs host disease - mortality (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
immunology (4) 4
retrospective studies (4) 4
stem cells (4) 4
survival analysis (4) 4
transplantation, homologous (4) 4
analysis (3) 3
child (3) 3
child, preschool (3) 3
graft vs host disease - etiology (3) 3
hemoglobin (3) 3
iron-deficiency (3) 3
proteins (3) 3
recurrence (3) 3
signal transduction (3) 3
treatment outcome (3) 3
allogeneic stem cell transplantation (2) 2
anemia, iron-deficiency - etiology (2) 2
anemia, iron-deficiency - prevention & control (2) 2
animals (2) 2
aspergillus-nidulans (2) 2
blood (2) 2
candida-albicans (2) 2
disease-free survival (2) 2
donation (2) 2
fungal proteins - genetics (2) 2
fungal proteins - metabolism (2) 2
fungi (2) 2
graft vs host disease - drug therapy (2) 2
graft vs host disease - pathology (2) 2
hematologic neoplasms - immunology (2) 2
hematologic neoplasms - mortality (2) 2
hematologic neoplasms - pathology (2) 2
hematologic neoplasms - therapy (2) 2
hematopoietic stem cells (2) 2
hemoglobins - analysis (2) 2
immunosuppressive agents - therapeutic use (2) 2
iron - metabolism (2) 2
iron deficiency (2) 2
lymphoma (2) 2
management (2) 2
medicine, general & internal (2) 2
mice (2) 2
microorganisms (2) 2
mortality (2) 2
myeloablative agonists - therapeutic use (2) 2
oncology (2) 2
prevention (2) 2
progress (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
research article (2) 2
risk factors (2) 2
saccharomyces-cerevisiae (2) 2
stem cell (2) 2
stores (2) 2
therapy (2) 2
transcription factors (2) 2
transcription factors - metabolism (2) 2
transplantation conditioning (2) 2
universities and colleges (2) 2
virulence (2) 2
abo blood-group system - immunology (1) 1
abridged index medicus (1) 1
access (1) 1
activating factor (1) 1
acute disease (1) 1
adaptation (1) 1
adenocarcinoma (1) 1
adp-ribosyl cyclase 1 - metabolism (1) 1
adverse events (1) 1
age (1) 1
aged, 80 and over (1) 1
aging (1) 1
algorithms (1) 1
alkalies - pharmacology (1) 1
alleles (1) 1
allergy (1) 1
allografts (1) 1
ambient ph (1) 1
ambient-ph (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transplantation, ISSN 0041-1337, 09/2015, Volume 99, Issue 9, pp. 1953 - 1959
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 5/2012, Volume 91, Issue 5, pp. 775 - 780
Risk factors for deferral from red blood cell (RBC) donation due to low hemoglobin are not well defined. We analyzed in a large cohort of returning donors the... 
Deferral | Medicine & Public Health | Hematology | Red blood cell donation | Ferritin | Hemoglobin | Oncology | Iron deficiency | IRON-DEFICIENCY | ANEMIA | IDENTIFICATION | HEMATOLOGY | MEAN CORPUSCULAR VOLUME | INDEXES | Young Adult | Blood Donors | Ferritins - blood | Humans | Middle Aged | Adolescent | Adult | Erythrocyte Indices | Female | Male | Aged | Anemia, Iron-Deficiency - blood
Journal Article
Transfusion, ISSN 0041-1132, 11/2013, Volume 53, Issue 11, pp. 2801 - 2806
Journal Article
BLOOD, ISSN 0006-4971, 03/2015, Volume 125, Issue 11, pp. 1830 - 1839
Journal Article
Transfusion, ISSN 0041-1132, 11/2013, Volume 53, Issue 11, pp. 2801 - 2806
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 7, pp. 1246 - 1250
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2875 - 2875
Abstract Introduction : Hairy cell leukemia (HCL) is a chronic mature B-cell neoplasm with a very indolent clinical course and patients may survive for many... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 82 - 86
Abstract Allogeneic stem cell transplant (SCT) after high-dose conditioning with BEAM/fludarabine/total body irradiation (TBI) in patients with relapsed or... 
Hematology, Oncology and Palliative Medicine | Allogeneic stem cell transplantation | Lymphoma | Autologous stem cell transplantation | RESPONSE CRITERIA | MALIGNANT-LYMPHOMA | BONE-MARROW-TRANSPLANTATION | BEAM CHEMOTHERAPY | FOLLICULAR LYMPHOMA | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | PROGNOSTIC INDEX | HODGKINS-LYMPHOMA | INTERNATIONAL WORKSHOP | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY | Graft vs Host Disease - therapy | Recurrence | Whole-Body Irradiation | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Myeloablative Agonists - adverse effects | Podophyllotoxin - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Lymphoma - mortality | Transplantation, Homologous | Stem Cell Transplantation | Graft vs Host Disease - mortality | Melphalan - adverse effects | Podophyllotoxin - administration & dosage | Adult | Female | Carmustine - adverse effects | Vidarabine - adverse effects | Leukemia, Lymphocytic, Chronic, B-Cell - prevention & control | Survival Rate | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Lymphoma - prevention & control | Myeloablative Agonists - administration & dosage | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Vidarabine - administration & dosage | Transplantation Conditioning | Carmustine - administration & dosage | Antimitotic agents | Transplantation | Lymphomas | Antineoplastic agents | Leukemia | Stem cells
Journal Article
Blood Transfusion, ISSN 1723-2007, 09/2016, Volume 14, Issue 5, pp. 391 - 399
Background. Safety of double-erythrocyte (2RBC) collection and reasons for ceasing 2RBC donation were retrospectively analysed in the blood donor population of... 
Adverse events | Donor retention | Double red blood cell apheresis | PREVIOUSLY UNTRAINED WOMEN | SAFETY | COLLECTIONS | double red blood cell apheresis | adverse events | IRON-DEFICIENCY | RETURN | WHOLE-BLOOD DONATION | ADAPTATION | ANEMIA | HEMATOLOGY | donor retention | PROGRAM | Blood Donors | Syncope, Vasovagal | Blood Component Removal | Donor Selection | Humans | Erythrocytes | Original
Journal Article
Transfusion, ISSN 0041-1132, 10/2012, Volume 52, Issue 10, pp. 2183 - 2188
Journal Article
Transfusion, ISSN 0041-1132, 10/2011, Volume 51, Issue 10, pp. 2183 - 2188
Journal Article